Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Entasis Therapeutics Holdings Inc (ETTX)

Entasis Therapeutics Holdings Inc (ETTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis Therapeutics Holdings Inc. (Nasdaq:...

INVA : 19.26 (-1.53%)
ETTX : 2.19 (-0.45%)
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TMX, HR, MN, MICT, ETTX

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TMX : 37.87 (-0.50%)
HR : 16.92 (-1.51%)
MN : 12.85 (+0.16%)
MICT : 0.9261 (+2.90%)
ETTX : 2.19 (-0.45%)
SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, ETTX, and TVTY Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

BHVN : 50.88 (+2.25%)
SWCH : 34.25 (+0.06%)
ETTX : 2.19 (-0.45%)
INVA : 19.26 (-1.53%)
TVTY : 32.50 (+0.06%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FHLT, TVTY, MN, ETTX

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FHLT : 10.96 (-7.51%)
TVTY : 32.50 (+0.06%)
MN : 12.85 (+0.16%)
ETTX : 2.19 (-0.45%)
SHAREHOLDER ALERT: Weiss Law Reminds ETTX, TVTY, MANT, and RTLR Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ETTX : 2.19 (-0.45%)
INVA : 19.26 (-1.53%)
TVTY : 32.50 (+0.06%)
MANT : 95.98 (-0.01%)
RTLR : 15.22 (+2.91%)
Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference

WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company...

ETTX : 2.19 (-0.45%)
Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Entasis Therapeutics Holdings Inc. (“Entasis”)...

ETTX : 2.19 (-0.45%)
INVA : 19.26 (-1.53%)
ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Entasis Therapeutics Holdings Inc. (NasdaqGM:...

ETTX : 2.19 (-0.45%)
INVA : 19.26 (-1.53%)
ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) to Innoviva, Inc. for $2.20 per share in cash is fair to Entasis shareholders....

ETTX : 2.19 (-0.45%)
Innoviva to Acquire Entasis Therapeutics

Innoviva to acquire all outstanding shares of Entasis it does not already own for $2.20 per share in cashPrice per share in cash represents a 50% premium...

INVA : 19.26 (-1.53%)
ETTX : 2.19 (-0.45%)

Barchart Exclusives

3 High-Yield Dividend Stocks Ready to Surge in 2025
These three companies pay above-average dividends, and their stocks still look cheap. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar